Thiazolidinediones News and Research

RSS
Thiazolidinediones are adjunctive therapies for diabetes mellitus (type 2) and related diseases.
Mystery underlying cardiac toxicity caused by diabetes drugs solved

Mystery underlying cardiac toxicity caused by diabetes drugs solved

New review on relationship between COPD and Type 2 diabetes

New review on relationship between COPD and Type 2 diabetes

Study suggests new possibilities for treating metabolic syndrome

Study suggests new possibilities for treating metabolic syndrome

Drug that treats diabetes found to exert powerful check on macrophages in controlling inflammation

Drug that treats diabetes found to exert powerful check on macrophages in controlling inflammation

Experimental diabetes drugs can make cancer cells vulnerable to chemotherapy agents

Experimental diabetes drugs can make cancer cells vulnerable to chemotherapy agents

Review highlights effective treatment options for managing patients with T2D and osteoporosis

Review highlights effective treatment options for managing patients with T2D and osteoporosis

ACP's clinical practice guidelines recommend effective treatment strategy for type 2 diabetes

ACP's clinical practice guidelines recommend effective treatment strategy for type 2 diabetes

Type 2 diabetes drug may someday help combat breast and ovarian cancers

Type 2 diabetes drug may someday help combat breast and ovarian cancers

New review shows both types of diabetes increase risk of fragility fractures

New review shows both types of diabetes increase risk of fragility fractures

Medical scientists examine potential new tool for helping prevent stroke, heart attack

Medical scientists examine potential new tool for helping prevent stroke, heart attack

Lilly receives FDA approval for Humulin R U-500 KwikPen

Lilly receives FDA approval for Humulin R U-500 KwikPen

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

Studies show AHA's Life's Simple 7 and Diabetes Shared Care Program reduce lifetime risk of heart failure

Studies show AHA's Life's Simple 7 and Diabetes Shared Care Program reduce lifetime risk of heart failure

LixiLan-O Phase III clinical trial meets primary endpoint in patients with type 2 diabetes

LixiLan-O Phase III clinical trial meets primary endpoint in patients with type 2 diabetes

FDA approves Humalog 200 units/mL KwikPen to improve glycemic control in diabetic patients

FDA approves Humalog 200 units/mL KwikPen to improve glycemic control in diabetic patients

Anti-diabetic medication activates brain sensors, promotes weight gain

Anti-diabetic medication activates brain sensors, promotes weight gain

Sanofi announces FDA approval of Toujeo insulin to improve glycemic control in people with diabetes

Sanofi announces FDA approval of Toujeo insulin to improve glycemic control in people with diabetes

New research suggests potential role for MEK inhibitors in type 2 diabetes

New research suggests potential role for MEK inhibitors in type 2 diabetes

'Achilles heel' in metabolic pathway could stop growth of lung cancer cells

'Achilles heel' in metabolic pathway could stop growth of lung cancer cells

Short-term use of DPP-4 inhibitors does not increase risk for pancreatic cancer

Short-term use of DPP-4 inhibitors does not increase risk for pancreatic cancer